{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:03:20Z","timestamp":1787645000371,"version":"build-2736575974"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Leipzig"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cardiovascular and oncological diseases represent the global major causes of death. For both, a novel and far-reaching risk factor has been identified: clonal hematopoiesis (CH). CH is defined as clonal expansion of peripheral blood cells on the basis of somatic mutations, without overt hematological malignancy. The most commonly affected genes are\n                    <jats:italic>TET2<\/jats:italic>\n                    ,\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    ,\n                    <jats:italic>ASXL1<\/jats:italic>\n                    and\n                    <jats:italic>JAK2<\/jats:italic>\n                    . By the age of 70, at least 20\u201350% of all individuals carry a CH clone, conveying a striking clinical impact by increasing all-cause mortality by 40%. This is due predominantly to a nearly two-fold increase of cardiovascular risk, but also to an elevated risk of malignant transformation. Individuals with CH show not only increased risk for, but also worse outcomes after arteriosclerotic events, such as stroke or myocardial infarction, decompensated heart failure and cardiogenic shock. Elevated cytokine levels, dysfunctional macrophage activity and activation of the inflammasome suggest that a vicious cycle of chronic inflammation and clonal expansion represents the major functional link. Despite the apparently high impact of this entity, awareness, functional understanding and especially clinical implications still require further research. This review provides an overview of the current knowledge of CH and its relation to cardiovascular and hematological diseases. It focuses on the basic functional mechanisms in the interplay between atherosclerosis, inflammation and CH, identifies issues for further research and considers potential clinical implications.\n                  <\/jats:p>","DOI":"10.1007\/s00395-022-00969-w","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T05:31:51Z","timestamp":1668058311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clonal hematopoiesis and cardiovascular disease: deciphering interconnections"],"prefix":"10.1007","volume":"117","author":[{"given":"Anna","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Metzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Kubasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Philipp","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Desch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Rosolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-998X","authenticated-orcid":false,"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"969_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","volume":"59","author":"SO Abegunde","year":"2018","unstructured":"Abegunde SO, Buckstein R, Wells RA et al (2018) An inflammatory environment containing TNF\u03b1 favors Tet2 -mutant clonal hematopoiesis. Exp Hematol 59:60\u201365. https:\/\/doi.org\/10.1016\/j.exphem.2017.11.002","journal-title":"Exp Hematol"},{"key":"969_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson S, Collord G, Ng SWK et al (2018) Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559:400\u2013404. https:\/\/doi.org\/10.1038\/s41586-018-0317-6","journal-title":"Nature"},{"key":"969_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.120.317104","volume":"128","author":"WT Abplanalp","year":"2021","unstructured":"Abplanalp WT, Cremer S, John D et al (2021) Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure. Circ Res 128:216\u2013228. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317104","journal-title":"Circ Res"},{"key":"969_CR4","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamacardio.2020.2468","volume":"5","author":"WT Abplanalp","year":"2020","unstructured":"Abplanalp WT, Mas-Peiro S, Cremer S et al (2020) Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure. JAMA Cardiol 5:1170\u20131175. https:\/\/doi.org\/10.1001\/jamacardio.2020.2468","journal-title":"JAMA Cardiol"},{"key":"969_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","volume":"101","author":"R Acuna-Hidalgo","year":"2017","unstructured":"Acuna-Hidalgo R, Sengul H, Steehouwer M et al (2017) Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life. Am J Hum Genet 101:50\u201364. https:\/\/doi.org\/10.1016\/j.ajhg.2017.05.013","journal-title":"Am J Hum Genet"},{"key":"969_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/circulationaha.118.039357","volume":"140","author":"G Agha","year":"2019","unstructured":"Agha G, Mendelson MM, Ward-Caviness CK et al (2019) Blood leukocyte DNA methylation predicts risk of future myocardial infarction and coronary heart disease. Circulation 140:645\u2013657. https:\/\/doi.org\/10.1161\/circulationaha.118.039357","journal-title":"Circulation"},{"key":"969_CR7","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","volume":"105","author":"CM Arends","year":"2019","unstructured":"Arends CM, Weiss M, Christen F et al (2019) Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Haematologica 105:e264\u2013e267. https:\/\/doi.org\/10.3324\/haematol.2019.223305","journal-title":"Haematologica"},{"key":"969_CR8","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1111\/cas.15094","volume":"112","author":"S Asada","year":"2021","unstructured":"Asada S, Kitamura T (2021) Clonal hematopoiesis and associated diseases: a review of recent findings. Cancer Sci 112:3962\u20133971. https:\/\/doi.org\/10.1111\/cas.15094","journal-title":"Cancer Sci"},{"key":"969_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","volume":"42","author":"B Assmus","year":"2021","unstructured":"Assmus B, Cremer S, Kirschbaum K et al (2021) Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. Eur Heart J 42:257\u2013265. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa845","journal-title":"Eur Heart J"},{"key":"969_CR10","doi-asserted-by":"publisher","first-page":"A16686","DOI":"10.1161\/circ.142.suppl_3.16686","volume":"142","author":"R Bhattacharya","year":"2020","unstructured":"Bhattacharya R (2020) Improved diet quality is associated with lower prevalence of clonal hematopoiesis of indeterminate potential. Circulation 142:A16686","journal-title":"Circulation"},{"key":"969_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","volume":"53","author":"R Bhattacharya","year":"2022","unstructured":"Bhattacharya R, Zekavat SM, Haessler J et al (2022) Clonal hematopoiesis is associated with higher risk of stroke. Stroke 53:788\u2013797. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037388","journal-title":"Stroke"},{"key":"969_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11883-021-00966-9","volume":"23","author":"R Bhattacharya","year":"2021","unstructured":"Bhattacharya R, Bick AG (2021) Clonal hematopoiesis of indeterminate potential: an expanding genetic cause of cardiovascular disease. Curr Atheroscler Rep 23:66. https:\/\/doi.org\/10.1007\/s11883-021-00966-9","journal-title":"Curr Atheroscler Rep"},{"key":"969_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","volume":"141","author":"AG Bick","year":"2020","unstructured":"Bick AG, Pirruccello JP, Griffin GK et al (2020) Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 141:124\u2013131. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044362","journal-title":"Circulation"},{"key":"969_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK et al (2020) Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586:763\u2013768. https:\/\/doi.org\/10.1038\/s41586-020-2819-2","journal-title":"Nature"},{"key":"969_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jacc.2022.08.740","volume":"80","author":"M B\u00f6hme","year":"2022","unstructured":"B\u00f6hme M, Desch S, Rosolowski M et al (2022) Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 80:1545\u20131556","journal-title":"J Am Coll Cardiol"},{"key":"969_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T et al (2020) Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet 52:1219\u20131226. https:\/\/doi.org\/10.1038\/s41588-020-00710-0","journal-title":"Nat Genet"},{"key":"969_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.18.00331","volume":"37","author":"KL Bolton","year":"2019","unstructured":"Bolton KL, Gillis NK, Coombs CC et al (2019) Managing clonal hematopoiesis in patients with solid tumors. J Clin Oncol 37:7\u201311. https:\/\/doi.org\/10.1200\/JCO.18.00331","journal-title":"J Clin Oncol"},{"key":"969_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/ng.2700","volume":"45","author":"A Bonnefond","year":"2013","unstructured":"Bonnefond A, Skrobek B, Lobbens S et al (2013) Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications. Nat Genet 45:1040\u20131043. https:\/\/doi.org\/10.1038\/ng.2700","journal-title":"Nat Genet"},{"key":"969_CR19","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/bloodadvances.2017010165","volume":"1","author":"AM Brunner","year":"2017","unstructured":"Brunner AM, Blonquist TM, Hobbs GS et al (2017) Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv 1:2032\u20132040. https:\/\/doi.org\/10.1182\/bloodadvances.2017010165","journal-title":"Blood Adv"},{"key":"969_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","volume":"130","author":"M Buscarlet","year":"2017","unstructured":"Buscarlet M, Provost S, Zada YF et al (2017) DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood 130:753\u2013762. https:\/\/doi.org\/10.1182\/blood-2017-04-777029","journal-title":"Blood"},{"key":"969_CR21","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1182\/bloodadvances.2019000770","volume":"4","author":"L Busque","year":"2020","unstructured":"Busque L, Sun M, Buscarlet M et al (2020) High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. Blood Adv 4:2430\u20132438. https:\/\/doi.org\/10.1182\/bloodadvances.2019000770","journal-title":"Blood Adv"},{"key":"969_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/stem.2845","volume":"36","author":"L Busque","year":"2018","unstructured":"Busque L, Buscarlet M, Mollica L et al (2018) Concise review: age-related clonal hematopoiesis: stem cells tempting the devil. Stem Cells 36:1287\u20131294. https:\/\/doi.org\/10.1002\/stem.2845","journal-title":"Stem Cells"},{"key":"969_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ng.2413","volume":"44","author":"L Busque","year":"2012","unstructured":"Busque L, Patel JP, Figueroa ME et al (2012) Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet 44:1179\u20131181. https:\/\/doi.org\/10.1038\/ng.2413","journal-title":"Nat Genet"},{"key":"969_CR24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006510","author":"G Challen","year":"2020","unstructured":"Challen G, Goodell MA (2020) Clonal hematopoiesis: mechanisms driving dominance of stem cell clones. Blood. https:\/\/doi.org\/10.1182\/blood.2020006510","journal-title":"Blood"},{"key":"969_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01469-x","author":"F Christen","year":"2021","unstructured":"Christen F, Hablesreiter R, Hoyer K et al (2021) Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR\/Cas9. Leukemia. https:\/\/doi.org\/10.1038\/s41375-021-01469-x","journal-title":"Leukemia"},{"key":"969_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino L, Dolgalev I, Wang Y et al (2017) Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170:1079-1095.e20. https:\/\/doi.org\/10.1016\/j.cell.2017.07.032","journal-title":"Cell"},{"key":"969_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","volume":"29","author":"I Cobo","year":"2021","unstructured":"Cobo I, Tanaka T, Glass CK et al (2021) Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease. Curr Opin Hematol 29:1\u20137. https:\/\/doi.org\/10.1097\/MOH.0000000000000688","journal-title":"Curr Opin Hematol"},{"key":"969_CR28","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","volume":"3","author":"EK Cook","year":"2019","unstructured":"Cook EK, Izukawa T, Young S et al (2019) Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis. Blood Adv 3:2482\u20132486. https:\/\/doi.org\/10.1182\/bloodadvances.2018024729","journal-title":"Blood Adv"},{"key":"969_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","volume":"21","author":"CC Coombs","year":"2017","unstructured":"Coombs CC, Zehir A, Devlin SM et al (2017) Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21:374-382.e4. https:\/\/doi.org\/10.1016\/j.stem.2017.07.010","journal-title":"Cell Stem Cell"},{"key":"969_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/circgen.120.003003","volume":"13","author":"S Cremer","year":"2020","unstructured":"Cremer S, Kirschbaum K, Berkowitsch A et al (2020) Multiple somatic mutations for clonal hematopoiesis are associated with increased mortality in patients with chronic heart failure. Circ Genom Precis Med 13:e003003. https:\/\/doi.org\/10.1161\/circgen.120.003003","journal-title":"Circ Genom Precis Med"},{"key":"969_CR31","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","volume":"34","author":"AAZ Dawoud","year":"2020","unstructured":"Dawoud AAZ, Tapper WJ, Cross NCP (2020) Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking. Leukemia 34:2660\u20132672. https:\/\/doi.org\/10.1038\/s41375-020-0896-8","journal-title":"Leukemia"},{"key":"969_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai P, Mencia-Trinchant N, Savenkov O et al (2018) Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med 24:1015\u20131023. https:\/\/doi.org\/10.1038\/s41591-018-0081-z","journal-title":"Nat Med"},{"key":"969_CR33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-021-01357-y","volume":"27","author":"NJ Dharan","year":"2021","unstructured":"Dharan NJ, Yeh P, Bloch M et al (2021) HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults. Nat Med 27:1006\u20131011. https:\/\/doi.org\/10.1038\/s41591-021-01357-y","journal-title":"Nat Med"},{"key":"969_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","volume":"559","author":"Wu Di","year":"2018","unstructured":"Di Wu, Di Hu, Chen H et al (2018) Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature 559:637\u2013641. https:\/\/doi.org\/10.1038\/s41586-018-0350-5","journal-title":"Nature"},{"key":"969_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer L, Assmus B, Rasper T et al (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4:25\u201333. https:\/\/doi.org\/10.1001\/jamacardio.2018.3965","journal-title":"JAMA Cardiol"},{"key":"969_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42003-022-03078-5","volume":"5","author":"I Dotan","year":"2022","unstructured":"Dotan I, Yang J, Ikeda J et al (2022) Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux. Commun Biol 5:132. https:\/\/doi.org\/10.1038\/s42003-022-03078-5","journal-title":"Commun Biol"},{"key":"969_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2019001807","volume":"135","author":"MA Fabre","year":"2020","unstructured":"Fabre MA, McKerrell T, Zwiebel M et al (2020) Concordance for clonal hematopoiesis is limited in elderly twins. Blood 135:269\u2013273. https:\/\/doi.org\/10.1182\/blood.2019001807","journal-title":"Blood"},{"key":"969_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood.V83.4.931.931","volume":"83","author":"MF Fey","year":"1994","unstructured":"Fey MF, Liechti-Gallati S, von Rohr A et al (1994) Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood 83:931\u2013938. https:\/\/doi.org\/10.1182\/blood.V83.4.931.931 (see comments)","journal-title":"Blood"},{"key":"969_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler TP, Xue C, Yalcinkaya M et al (2021) The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature 592:296\u2013301. https:\/\/doi.org\/10.1038\/s41586-021-03341-5","journal-title":"Nature"},{"key":"969_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22053-y","author":"T Fujino","year":"2021","unstructured":"Fujino T, Goyama S, Sugiura Y et al (2021) Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt\/mTOR pathway. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-22053-y","journal-title":"Nat Commun"},{"key":"969_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108326","volume":"33","author":"JJ Fuster","year":"2020","unstructured":"Fuster JJ, Zuriaga MA, Zorita V et al (2020) TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity. Cell Rep 33:108326. https:\/\/doi.org\/10.1016\/j.celrep.2020.108326","journal-title":"Cell Rep"},{"key":"969_CR42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA et al (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355:842\u2013847. https:\/\/doi.org\/10.1126\/science.aag1381","journal-title":"Science"},{"key":"969_CR43","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE et al (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. NEJM 371:2477\u20132487. https:\/\/doi.org\/10.1056\/NEJMoa1409405","journal-title":"NEJM"},{"key":"969_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.2019001793","volume":"135","author":"JW Hansen","year":"2020","unstructured":"Hansen JW, Pedersen DA, Larsen LA et al (2020) Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality. Blood 135:261\u2013268. https:\/\/doi.org\/10.1182\/blood.2019001793","journal-title":"Blood"},{"key":"969_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018789","volume":"10","author":"B Haring","year":"2021","unstructured":"Haring B, Reiner AP, Liu J et al (2021) Healthy lifestyle and clonal hematopoiesis of indeterminate potential: results from the women\u2019s health initiative. J Am Heart Assoc 10:e018789. https:\/\/doi.org\/10.1161\/JAHA.120.018789","journal-title":"J Am Heart Assoc"},{"key":"969_CR46","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1182\/blood.2020010163","volume":"138","author":"JS Hecker","year":"2021","unstructured":"Hecker JS, Hartmann L, Rivi\u00e8re J et al (2021) CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease. Blood 138:1727\u20131732. https:\/\/doi.org\/10.1182\/blood.2020010163","journal-title":"Blood"},{"key":"969_CR47","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cell.2021.01.049","volume":"184","author":"A Heyde","year":"2021","unstructured":"Heyde A, Rohde D, McAlpine CS et al (2021) Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis. Cell 184:1348-1361.e22. https:\/\/doi.org\/10.1016\/j.cell.2021.01.049","journal-title":"Cell"},{"key":"969_CR48","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","volume":"128","author":"DA Hinds","year":"2016","unstructured":"Hinds DA, Barnholt KE, Mesa RA et al (2016) Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 128:1121\u20131128. https:\/\/doi.org\/10.1182\/blood-2015-06-652941","journal-title":"Blood"},{"key":"969_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.051775","volume":"143","author":"MC Honigberg","year":"2021","unstructured":"Honigberg MC, Zekavat SM, Niroula A et al (2021) Premature menopause, clonal hematopoiesis, and coronary artery disease in postmenopausal women. Circulation 143:410\u2013423. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051775","journal-title":"Circulation"},{"key":"969_CR50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","volume":"23","author":"JI Hsu","year":"2018","unstructured":"Hsu JI, Dayaram T, Tovy A et al (2018) PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23:700-713.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.10.004","journal-title":"Cell Stem Cell"},{"key":"969_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.immuni.2015.03.005","volume":"42","author":"K Ichiyama","year":"2015","unstructured":"Ichiyama K, Chen T, Wang X et al (2015) The methylcytosine dioxygenase Tet2 Promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42:613\u2013626. https:\/\/doi.org\/10.1016\/j.immuni.2015.03.005","journal-title":"Immunity"},{"key":"969_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S, Libby P (2020) Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol 17:137\u2013144. https:\/\/doi.org\/10.1038\/s41569-019-0247-5","journal-title":"Nat Rev Cardiol"},{"key":"969_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL (2019) Clonal hematopoiesis in human aging and disease. Science. https:\/\/doi.org\/10.1126\/science.aan4673","journal-title":"Science"},{"key":"969_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. NEJM 377:111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1701719","journal-title":"NEJM"},{"key":"969_CR55","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. NEJM 371:2488\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa1408617","journal-title":"NEJM"},{"key":"969_CR56","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/ehf2.13297","volume":"8","author":"KC Kiefer","year":"2021","unstructured":"Kiefer KC, Cremer S, Pardali E et al (2021) Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality. ESC Heart Fail 8:1873\u20131884. https:\/\/doi.org\/10.1002\/ehf2.13297","journal-title":"ESC Heart Fail"},{"key":"969_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cas.14688","volume":"112","author":"H Kunimoto","year":"2021","unstructured":"Kunimoto H, Nakajima H (2021) TET2: a cornerstone in normal and malignant hematopoiesis. Cancer Sci 112:31\u201340. https:\/\/doi.org\/10.1111\/cas.14688","journal-title":"Cancer Sci"},{"key":"969_CR58","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1038\/s41598-022-09604-z","volume":"12","author":"MG Levin","year":"2022","unstructured":"Levin MG, Nakao T, Zekavat SM et al (2022) Genetics of smoking and risk of clonal hematopoiesis. Sci Rep 12:7248. https:\/\/doi.org\/10.1038\/s41598-022-09604-z","journal-title":"Sci Rep"},{"key":"969_CR59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P (2021) The changing landscape of atherosclerosis. Nature 592:524\u2013533. https:\/\/doi.org\/10.1038\/s41586-021-03392-8","journal-title":"Nature"},{"key":"969_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11745-014-3977-5","volume":"50","author":"G Li","year":"2015","unstructured":"Li G, Peng J, Liu Y et al (2015) Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation. Lipids 50:177\u2013183. https:\/\/doi.org\/10.1007\/s11745-014-3977-5","journal-title":"Lipids"},{"key":"969_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41569-020-00481-5","volume":"18","author":"GB Lim","year":"2020","unstructured":"Lim GB (2020) Clonal haematopoiesis induces a pro-inflammatory monocyte phenotype in HF. Nat Rev Cardiol 18:74. https:\/\/doi.org\/10.1038\/s41569-020-00481-5","journal-title":"Nat Rev Cardiol"},{"key":"969_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809955","volume":"9","author":"L Lin","year":"2021","unstructured":"Lin L, Zhang M-X, Zhang L et al (2021) Autophagy, pyroptosis, and ferroptosis: new regulatory mechanisms for atherosclerosis. Front Cell Dev Biol 9:809955. https:\/\/doi.org\/10.3389\/fcell.2021.809955","journal-title":"Front Cell Dev Biol"},{"key":"969_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.806988","volume":"8","author":"Z Lin","year":"2021","unstructured":"Lin Z, Ding Q, Li X et al (2021) Targeting epigenetic mechanisms in vascular aging. Front Cardiovasc Med 8:806988. https:\/\/doi.org\/10.3389\/fcvm.2021.806988","journal-title":"Front Cardiovasc Med"},{"key":"969_CR64","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ni.3464","volume":"17","author":"X Li","year":"2016","unstructured":"Li X, Zhang Q, Ding Y et al (2016) Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nat Immunol 17:806\u2013815. https:\/\/doi.org\/10.1038\/ni.3464","journal-title":"Nat Immunol"},{"key":"969_CR65","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"P-R Loh","year":"2018","unstructured":"Loh P-R, Genovese G, Handsaker RE et al (2018) Insights into clonal haematopoiesis from 8342 mosaic chromosomal alterations. Nature 559:350\u2013355. https:\/\/doi.org\/10.1038\/s41586-018-0321-x","journal-title":"Nature"},{"key":"969_CR66","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","volume":"41","author":"S Mas-Peiro","year":"2020","unstructured":"Mas-Peiro S, Hoffmann J, Fichtlscherer S et al (2020) Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart J 41:933\u2013939. https:\/\/doi.org\/10.1093\/eurheartj\/ehz591","journal-title":"Eur Heart J"},{"key":"969_CR67","doi-asserted-by":"publisher","first-page":"20087","DOI":"10.1073\/pnas.1909849116","volume":"116","author":"F Mba Medie","year":"2019","unstructured":"Mba Medie F, Sharma-Kuinkel BK, Ruffin F et al (2019) Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients. Proc Natl Acad Sci U S A 116:20087\u201320096. https:\/\/doi.org\/10.1073\/pnas.1909849116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"969_CR68","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel M, Hinterleitner R, Pacis A et al (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580\u2013584. https:\/\/doi.org\/10.1038\/s41586-018-0125-z","journal-title":"Nature"},{"key":"969_CR69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell E, Spencer Chapman M, Williams N et al (2022) Clonal dynamics of haematopoiesis across the human lifespan. Nature 606:343\u2013350. https:\/\/doi.org\/10.1038\/s41586-022-04786-y","journal-title":"Nature"},{"key":"969_CR70","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.rec.2021.05.005","volume":"74","author":"L Palomo","year":"2021","unstructured":"Palomo L, Santiago-Vacas E, Pascual-Figal D et al (2021) Prevalence and characteristics of clonal hematopoiesis in heart failure. Rev Esp Cardiol (Engl Ed) 74:996\u2013999. https:\/\/doi.org\/10.1016\/j.rec.2021.05.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"969_CR71","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","volume":"77","author":"DA Pascual-Figal","year":"2021","unstructured":"Pascual-Figal DA, Bayes-Genis A, D\u00edez-D\u00edez M et al (2021) Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction. J Am Coll Cardiol 77:1747\u20131759. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.028","journal-title":"J Am Coll Cardiol"},{"key":"969_CR72","doi-asserted-by":"publisher","first-page":"76423","DOI":"10.18632\/oncotarget.13121","volume":"7","author":"J Peng","year":"2016","unstructured":"Peng J, Yang Q, Li A-F et al (2016) Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE\u2013\/\u2013 mice. Oncotarget 7:76423\u201376436. https:\/\/doi.org\/10.18632\/oncotarget.13121","journal-title":"Oncotarget"},{"key":"969_CR73","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00018-009-0015-5","volume":"66","author":"IP Pogribny","year":"2009","unstructured":"Pogribny IP, Beland FA (2009) DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 66:2249\u20132261. https:\/\/doi.org\/10.1007\/s00018-009-0015-5","journal-title":"Cell Mol Life Sci"},{"key":"969_CR74","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41588-021-00957-1","volume":"53","author":"GYP Poon","year":"2021","unstructured":"Poon GYP, Watson CJ, Fisher DS et al (2021) Synonymous mutations reveal genome-wide levels of positive selection in healthy tissues. Nat Genet 53:1597\u20131605. https:\/\/doi.org\/10.1038\/s41588-021-00957-1","journal-title":"Nat Genet"},{"key":"969_CR75","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/circulationaha.119.044320","volume":"141","author":"F Potus","year":"2020","unstructured":"Potus F, Pauciulo MW, Cook EK et al (2020) Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension. Circulation 141:1986\u20132000. https:\/\/doi.org\/10.1161\/circulationaha.119.044320","journal-title":"Circulation"},{"key":"969_CR76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s42003-022-03057-w","volume":"5","author":"E Pronier","year":"2022","unstructured":"Pronier E, Imanci A, Selimoglu-Buet D et al (2022) Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes. Commun Biol 5:110. https:\/\/doi.org\/10.1038\/s42003-022-03057-w","journal-title":"Commun Biol"},{"key":"969_CR77","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 377:1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"NEJM"},{"key":"969_CR78","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/circresaha.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y et al (2018) CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ Res 123:335\u2013341. https:\/\/doi.org\/10.1161\/circresaha.118.313225","journal-title":"Circ Res"},{"key":"969_CR79","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y et al (2018) Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol 71:875\u2013886. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.037","journal-title":"J Am Coll Cardiol"},{"key":"969_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15869","author":"P Savola","year":"2017","unstructured":"Savola P, Kelkka T, Rajala HL et al (2017) Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms15869","journal-title":"Nat Commun"},{"key":"969_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2588","author":"FL Scolari","year":"2022","unstructured":"Scolari FL, Abelson S, Brahmbhatt DH et al (2022) Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2588","journal-title":"Eur J Heart Fail"},{"key":"969_CR82","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1055\/s-0041-1733856","volume":"5","author":"S Soudet","year":"2021","unstructured":"Soudet S, Jedraszak G, Evrard O et al (2021) Is hematopoietic clonality of indetermined potential a risk factor for pulmonary embolism? TH Open 5:e338\u2013e342. https:\/\/doi.org\/10.1055\/s-0041-1733856","journal-title":"TH Open"},{"key":"969_CR83","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1182\/blood.2019004291","volume":"136","author":"DP Steensma","year":"2020","unstructured":"Steensma DP, Bolton KL (2020) What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics. Blood 136:1623\u20131631. https:\/\/doi.org\/10.1182\/blood.2019004291","journal-title":"Blood"},{"key":"969_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S et al (2015) Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126:9\u201316. https:\/\/doi.org\/10.1182\/blood-2015-03-631747","journal-title":"Blood"},{"key":"969_CR85","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson EC, Madar A, Campbell CD et al (2022) TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol 7:521\u2013528. https:\/\/doi.org\/10.1001\/jamacardio.2022.0386","journal-title":"JAMA Cardiol"},{"key":"969_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2017.208","volume":"15","author":"FK Swirski","year":"2017","unstructured":"Swirski FK (2017) From clonal haematopoiesis to the CANTOS trial. Nat Rev Cardiol 15:79\u201380. https:\/\/doi.org\/10.1038\/nrcardio.2017.208","journal-title":"Nat Rev Cardiol"},{"key":"969_CR87","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","volume":"5","author":"IA van Zeventer","year":"2021","unstructured":"van Zeventer IA, Salzbrunn JB, de Graaf AO et al (2021) Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u2265 80 years. Blood Adv 5:2115\u20132122. https:\/\/doi.org\/10.1182\/bloodadvances.2020004062","journal-title":"Blood Adv"},{"key":"969_CR88","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/0008-5472.CAN-20-3033","volume":"81","author":"K Venugopal","year":"2021","unstructured":"Venugopal K, Feng Y, Shabashvili D et al (2021) Alterations to DNMT3A in hematologic malignancies. Cancer Res 81:254\u2013263. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3033","journal-title":"Cancer Res"},{"key":"969_CR89","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/circresaha.118.313283","volume":"123","author":"W Wang","year":"2018","unstructured":"Wang W, Liu W, Fidler T et al (2018) Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 V617F mice. Circ Res 123:e35\u2013e47. https:\/\/doi.org\/10.1161\/circresaha.118.313283","journal-title":"Circ Res"},{"key":"969_CR90","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson CJ, Papula AL, Poon GYP et al (2020) The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 367:1449\u20131454. https:\/\/doi.org\/10.1126\/science.aay9333","journal-title":"Science"},{"key":"969_CR91","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8292","author":"O Wolach","year":"2018","unstructured":"Wolach O, Sellar RS, Martinod K et al (2018) Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan8292","journal-title":"Sci Transl Med"},{"key":"969_CR92","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41467-018-02858-0","volume":"9","author":"TN Wong","year":"2018","unstructured":"Wong TN, Miller CA, Jotte MRM et al (2018) Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nat Commun 9:455. https:\/\/doi.org\/10.1038\/s41467-018-02858-0","journal-title":"Nat Commun"},{"key":"969_CR93","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s10439-015-1491-4","volume":"44","author":"Q Yang","year":"2016","unstructured":"Yang Q, Li X, Li R et al (2016) Low shear stress inhibited endothelial cell autophagy through TET2 downregulation. Ann Biomed Eng 44:2218\u20132227. https:\/\/doi.org\/10.1007\/s10439-015-1491-4","journal-title":"Ann Biomed Eng"},{"key":"969_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12484","author":"AL Young","year":"2016","unstructured":"Young AL, Challen GA, Birmann BM et al (2016) Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms12484","journal-title":"Nat Commun"},{"key":"969_CR95","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2021.04.085","volume":"78","author":"B Yu","year":"2021","unstructured":"Yu B, Roberts MB, Raffield LM et al (2021) Supplemental association of clonal hematopoiesis with incident heart failure. J Am Coll Cardiol 78:42\u201352. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.085","journal-title":"J Am Coll Cardiol"},{"key":"969_CR96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","volume":"80","author":"CR Zhang","year":"2019","unstructured":"Zhang CR, Nix D, Gregory M et al (2019) Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol 80:36-41.e3. https:\/\/doi.org\/10.1016\/j.exphem.2019.11.008","journal-title":"Exp Hematol"},{"key":"969_CR97","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41388-018-0524-5","volume":"38","author":"J Zhang","year":"2019","unstructured":"Zhang J, Tan P, Guo L et al (2019) p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Oncogene 38:1905\u20131919. https:\/\/doi.org\/10.1038\/s41388-018-0524-5","journal-title":"Oncogene"},{"key":"969_CR98","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL et al (2017) Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130:742\u2013752. https:\/\/doi.org\/10.1182\/blood-2017-02-769869","journal-title":"Blood"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00969-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-022-00969-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00969-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T07:11:10Z","timestamp":1675062670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-022-00969-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1007\/s00395-022-00969-w","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"55"}}